Yuanxin Technology Closes ￥600M Series D1 Funding Round
According to VCBeat, Beijing Yuanxin Technology Co., Ltd. ("Yuanxin Technology") announced recently the completion of ￥600 million Series D1 round 600 million yuan, with participation from Qiming Venture Partners, INCE Capital, Sequoia Capital, CITIC Securities, Index Capital and others. This is another round of Yuanxin Technology since the closing of Series C3 financing in June 2019.
The funds will be used for the development of the "healthcare, medication, insurance" business model of Yuanxin Technology, with the combination of Miaoshou online hospitals, prescription management, and health insurance.
Founded in 2015, Yuanxin Technology now has 5 leading brands: Miao Shou Doctor, Yuanxin Medical, Yuanxin Chain Pharmacy, Yuanxin Insurance, and Wujie Jinxiu (an online platform for further education of medical workers). Yuanxin Technology is a leader in several fields of Internet operation and solutions of physical and urban medical services, Internet hospitals, out-of-hospital prescription and DTP business, health insurance, and TPA services.
Relying on the advantages of Internet technology, Yuanxin Technology fully combines medical service, pharmaceutical service and insurance service to build the service system of "doctors, patients, medication and insurance".
He Tao, founder and CEO of Yuanxin Technology, said the company will always provide quality services for patients and partners focusing on "healthcare-medication-insurance".
About Qiming Venture Partners
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen, Hong Kong, Seattle, Boston, and San Francisco Bay Area. Currently, Qiming Venture Partners manages seven US Dollar funds and five RMB funds with over US$4 billion assets under management. Qiming Venture Partners invests in information technology, new consumer business patterns, and the healthcare sector.
About INCE Capital
INCE Capital is a new fund that will invest in early-stage consumer-related technology companies in China.